The global relapsed or refractory diffuse large B-cell lymphoma market is rapidly gaining momentum owing to technological advancements in immunotherapy. Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of non-Hodgkin's lymphoma. It occurs when abnormal B-lymphocytes grow uncontrolled and crowd out normal cells of the immune system. Relapsed or refractory DLBCL refers to the...
0 Commentarios
0 Acciones
137 Views
0 Vista previa